You are here

  • Home
  • Archive
  • Volume 13, Issue 3
  • Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach

Article metrics

Article menu
Download PDFPDF
Innovations in Treatment
Case report
Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach

 

Online download statistics by month:

Online download statistics by month: March 2020 to March 2023

AbstractFullPdf
Mar 202033558
Apr 20208572834
May 20203432734
Jun 202017648
Jul 20201191010
Aug 2020129149
Sep 202015799
Oct 20208597
Nov 2020160138
Dec 202099105
Jan 2021164108
Feb 20219567
Mar 20219136
Apr 202119866
May 20214066
Jun 202121117
Jul 2021843
Aug 202116114
Sep 2021735
Oct 2021117119
Nov 20217311
Dec 202110240
Jan 202210214
Feb 20227847
Mar 202212246
Apr 20227691
May 20224906
Jun 20229232
Jul 20225042
Aug 20226311
Sep 20227750
Oct 20226363
Nov 20224951
Dec 20224311
Jan 20234311
Feb 202312272
Mar 20232010
Total4441257231